Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (32)
Hanan S. Althagafy, Mostafa K. Abd El-Aziz, Islam M. Ibrahim, Esraa K. Abd-alhameed & Emad H.M. Hassanein. (2023) Pharmacological updates of nifuroxazide: Promising preclinical effects and the underlying molecular mechanisms. European Journal of Pharmacology 951, pages 175776.
Crossref
Crossref
Krzysztof Milewski, Anna Maria Czarnecka, Jan Albrecht & Magdalena Zielińska. (2021) Decreased Expression and Uncoupling of Endothelial Nitric Oxide Synthase in the Cerebral Cortex of Rats with Thioacetamide-Induced Acute Liver Failure. International Journal of Molecular Sciences 22:13, pages 6662.
Crossref
Crossref
Joji Tani, Asahiro Morishita, Teppei Sakamoto, Kei Takuma, Mai Nakahara, Koji Fujita, Kyoko Oura, Tomoko Tadokoro, Shima Mimura, Takako Nomura, Hirohito Yoneyama, Hideki Kobara, Takashi Himoto & Tsutomu Masaki. (2020) L-carnitine reduces hospital admissions in patients with hepatic encephalopathy. European Journal of Gastroenterology & Hepatology 32:2, pages 288-293.
Crossref
Crossref
Georg Berding, Frank Bengel & Karin Weissenborn. 2021. PET and SPECT in Neurology. PET and SPECT in Neurology
947
965
.
Weijia Han, Huanqian Zhang, Ying Han & Zhongping Duan. (2020) Cognition-tracking-based strategies for diagnosis and treatment of minimal hepatic encephalopathy. Metabolic Brain Disease 35:6, pages 869-881.
Crossref
Crossref
Pedro Arend Guazzelli, Giordano Fabricio Cittolin-Santos, Leo Anderson Meira-Martins, Mateus Grings, Yasmine Nonose, Gabriel S. Lazzarotto, Daniela Nogara, Jussemara S. da Silva, Fernanda U. Fontella, Moacir Wajner, Guilhian Leipnitz, Diogo O. Souza & Adriano Martimbianco de Assis. (2020) Acute Liver Failure Induces Glial Reactivity, Oxidative Stress and Impairs Brain Energy Metabolism in Rats. Frontiers in Molecular Neuroscience 12.
Crossref
Crossref
Hendrik Strebel, Bernhard Haller, Maximilian Sohn, Wolfgang Schepp & Felix Gundling. (2020) Role of Brain Biomarkers S-100-Beta and Neuron-Specific Enolase for Detection and Follow-Up of Hepatic Encephalopathy in Cirrhosis before, during and after Treatment with L-Ornithine-L-Aspartate. GE - Portuguese Journal of Gastroenterology 27:6, pages 391-403.
Crossref
Crossref
Mohammad Mohai El-Din Awad, Abd-El Raouf Mohamed El-Deib, Fadia Mostafa Attia, Mohamed Negm, Mohamed Hassan Mohamed Soliman & Wafaa Hassan Omar. (2019) Role of minimal hepatic encephalopathy in road traffic accidents. The Egyptian Journal of Neurology, Psychiatry and Neurosurgery 55:1.
Crossref
Crossref
Arturo J Martí-Carvajal, Christian Gluud, Ingrid Arevalo-Rodriguez & Cristina Elena Martí-Amarista. (2019) Acetyl-L-carnitine for patients with hepatic encephalopathy. Cochrane Database of Systematic Reviews 2019:1.
Crossref
Crossref
Wen-Rui Xie, Xiao-Ya Yang, Harry Hua-Xiang Xia & Xing-Xiang He. (2018) Fecal Microbiota Transplantation for Treating Hepatic Encephalopathy: Experimental and Clinical Evidence and Possible Underlying Mechanisms. Journal of Exploratory Research in Pharmacology 3:4, pages 105-110.
Crossref
Crossref
Arijit Nath, Gokce Haktanirlar, Áron Varga, Máté András Molnár, Krisztina Albert, Ildikó Galambos, András Koris & Gyula Vatai. (2018) Biological Activities of Lactose-Derived Prebiotics and Symbiotic with Probiotics on Gastrointestinal System. Medicina 54:2, pages 18.
Crossref
Crossref
Paolo Feltracco, Annachiara Cagnin, Cristiana Carollo, Stefania Barbieri & Carlo Ori. (2017) Neurological disorders in liver transplant candidates: Pathophysiology and clinical assessment. Transplantation Reviews 31:3, pages 193-206.
Crossref
Crossref
Saleh Elwir, Hassan Hal, Joshua Veith, Ian Schreibman, Zakiyah Kadry & Thomas Riley. (2016) Radiographical findings in patients with liver cirrhosis and hepatic encephalopathy. Gastroenterology Report 4:3, pages 221-225.
Crossref
Crossref
Jonathan A. Lidbury, Audrey K. Cook & Jörg M. Steiner. (2016) Hepatic encephalopathy in dogs and cats. Journal of Veterinary Emergency and Critical Care 26:4, pages 471-487.
Crossref
Crossref
Olivia Tiberi, Joshua M Tognarelli, Nicola A Cook, Mary ME Crossey, Novraj S Dhanjal & Simon D Taylor-Robinson. (2015) Diagnosing and treating hepatic encephalopathy. British Journal of Hospital Medicine 76:11, pages 646-654.
Crossref
Crossref
Adam G. Gow, Polly E. Frowde, Clive M. Elwood, Carolyn A. Burton, Roger M. Powell, Simon W. Tappin, Rob D. Foale, Andrew Duncan & Richard J. Mellanby. (2015) Surgical attenuation of spontaneous congenital portosystemic shunts in dogs resolves hepatic encephalopathy but not hypermanganesemia. Metabolic Brain Disease 30:5, pages 1285-1289.
Crossref
Crossref
N. Soni, R. Gupta & S. Kumar. (2015) Brain MR imaging in neurologic complications of post living donor liver transplant recipients. Indian Journal of Transplantation 9:1, pages 13-29.
Crossref
Crossref
Arturo J Martí-Carvajal, Christian Gluud & Ingrid Arevalo-Rodriguez. (2014) Acetyl-L-carnitine for patients with hepatic encephalopathy. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Juli Alonso, Juan Córdoba & Alex Rovira. (2014) Brain Magnetic Resonance in Hepatic Encephalopathy. Seminars in Ultrasound, CT and MRI 35:2, pages 136-152.
Crossref
Crossref
Georg Berding, Frank Bengel & Karin Weissenborn. 2014. PET and SPECT in Neurology. PET and SPECT in Neurology
797
814
.
Kensuke Nakamura, Kiyomi Yamane, Kazuaki Shinohara, Kent Doi, Ryota Inokuchi, Takahiro Hiruma, Susumu Nakajima, Eisei Noiri & Naoki Yahagi. (2013) Hyperammonemia in idiopathic epileptic seizure. The American Journal of Emergency Medicine 31:10, pages 1486-1489.
Crossref
Crossref
Qian Jiang, Gang Jiang, Ke-qing Shi, Hong Cai, Yi-xin Wang & Ming-hua Zheng. (2013) Oral Acetyl-L-Carnitine treatment in hepatic encephalopathy: view of evidence-based medicine. Annals of Hepatology 12:5, pages 803-809.
Crossref
Crossref
Liliana Rivera-Espinosa, Esaú Floriano-Sánchez, José Pedraza-Chaverrí, Elvia Coballase-Urrutia, Aristides Sampieri, Daniel Ortega-Cuellar, Noemí Cárdenas-Rodríguez & Liliana Carmona-Aparicio. (2013) Contributions of Microdialysis to New Alternative Therapeutics for Hepatic Encephalopathy. International Journal of Molecular Sciences 14:8, pages 16184-16206.
Crossref
Crossref
Michele Malaguarnera. (2013) Acetyl-L-carnitine in hepatic encephalopathy. Metabolic Brain Disease 28:2, pages 193-199.
Crossref
Crossref
Lewis W. Teperman. (2013) Impact of Pretransplant Hepatic Encephalopathy on Liver Posttransplantation Outcomes. International Journal of Hepatology 2013, pages 1-9.
Crossref
Crossref
Dong Wu, Shu-Mei Wu, Jie Lu, Ying-Qun Zhou, Ling Xu & Chuan-Yong Guo. (2013) Rifaximin versus Nonabsorbable Disaccharides for the Treatment of Hepatic Encephalopathy: A Meta-Analysis. Gastroenterology Research and Practice 2013, pages 1-9.
Crossref
Crossref
Felix Gundling, Edin Zelihic, Holger Seidl, Bernhard Haller, Andreas Umgelter, Wolfgang Schepp & Christoph Dodt. (2013) How to diagnose hepatic encephalopathy in the emergency department. Annals of Hepatology 12:1, pages 108-114.
Crossref
Crossref
Jyoti Sureka, Ravi Kanth Jakkani & Sanuj Panwar. (2012) MRI findings in acute hyperammonemic encephalopathy resulting from decompensated chronic liver disease. Acta Neurologica Belgica 112:2, pages 221-223.
Crossref
Crossref
Vicente Felipo, Amparo Urios, Encarna Montesinos, Inmaculada Molina, Maria L. Garcia-Torres, Miguel Civera, Juan A. Del Olmo, Joaquin Ortega, Jose Martinez-Valls, Miguel A. Serra, Norberto Cassinello, Abdallah Wassel, Esperanza Jordá & Carmina Montoliu. (2011) Contribution of hyperammonemia and inflammatory factors to cognitive impairment in minimal hepatic encephalopathy. Metabolic Brain Disease 27:1, pages 51-58.
Crossref
Crossref
Manuela Merli, Michela Giusto & Oliviero Riggio. 2012. Hepatic Encephalopathy. Hepatic Encephalopathy
199
209
.
Tzu-Yao Hung, Chien-Chih Chen, Tzong-Luen Wang, Chih-Feng Su & Ruei-Fang Wang. (2011) Transient hyperammonemia in seizures: A prospective study. Epilepsia 52:11, pages 2043-2049.
Crossref
Crossref
Felix Gundling, Fabian Schmidtler, Alexander Hapfelmeier, Benjamin Schulte, Thomas Schmidt, Christian Pehl, Wolfgang Schepp & Holger Seidl. (2011) Fecal calprotectin is a useful screening parameter for hepatic encephalopathy and spontaneous bacterial peritonitis in cirrhosis. Liver International 31:9, pages 1406-1415.
Crossref
Crossref